7.59
7.59 (0%)
As of Sep 20, 2024
Trxade Health, Inc [MEDS]
Source:
Company Overview
ScientureLLC is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of CNS and CVS diseases.Scienture LLC is developing a broad range of novel product candidates including new potential treatments for hypertension, migraine,pain and thrombosis and other related disorders.
| Country | United States |
| Headquarters | lutz, florida |
| Phone Number | (800) 261 0281 |
| Industry | wholesale |
| CEO | Suren Ajjarapu |
| Website | rx.trxade.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0.1 |
| Operating Profit | $-14.7 |
| Net Income | $9.1 |
| Net Cash | $0.3 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | -10,758.7 |
| Profit as % of Revenues | 0.1% |
| Profit as % of Assets | 15.5% |
| Profit as % of Stockholder Equity | 11.5% |
Management Effectiveness
| Return on Equity | 11.5% |
| Return on Assets | 8.7% |
| Turnover Ratio | 0.2% |
| EBITA | $-14.7 |
Balance Sheet and Cash Flow Measures
| Total Assets | $104.9 |
| Total Liabilities | $25.8 |
| Operating Cash Flow | $-14.3 |
| Investing Cash Flow | $27.6 |
| Financing Cash Flow | $-13 |
